Galvus Met is a combination medication containing Vildagliptin and Metformin. Vildagliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which leads to increased insulin release and decreased glucagon levels, thereby helping to control blood sugar levels. Metformin reduces glucose production in the liver and improves insulin sensitivity in the muscles. This combination helps in the management of type 2 diabetes mellitus by regulating blood sugar levels.